U.S. Army research biologist from Maryland sentenced To 51 months in prison for engaging in APG bribery scheme

BALTIMORE, MD—A U.S. Army biologist from Maryland will be spending time behind bars for participating in a bribery scheme. Jason Edmonds, 45 of North East, was sentenced this week to 51 months in federal prison and 3 years of supervised release for conspiring to commit bribery at the Aberdeen Proving Ground. In addition, the Court ordered Edmonds to forfeit $111,794.83, […]

Labcorp agrees to pay over $2 million to settle False Claims Act allegations related to overbillings on Department of Defense contracts

BALTIMORE, MD—Laboratory Corporation of America has agreed to pay the U.S. $2,100,000 to resolve allegations that it violated the federal False Claims Act by overbilling the Department of Defense for genetic tests performed by GeneDx, LLC, a third-party reference laboratory used by Labcorp to perform genetic tests for military members. The civil settlement was announced by United States Attorney for […]

Kingsville CEO admits to bribing Aberdeen Proving Ground biochemist researcher in exchange for government contracts

BALTIMORE, MD—A Kingsville CEO has pleaded guilty to bribing a researcher at Aberdeen Proving Ground in exchange for government contracts.  John R. Conigliaro, 60, has pleaded guilty to conspiracy to bribe a public official. The guilty plea was announced by United States Attorney for the District of Maryland Erek L. Barron; Special Agent in Charge Thomas J. Sobocinski of the […]

Kingsville, North East men charged in bribery scheme at Aberdeen Proving Ground

BALTIMORE, MD—A federal grand jury has returned an indictment charging two men in connection with a bribery scheme at Aberdeen Proving Ground. Jason Edmonds, 43, of North East, has been charged with conspiracy and bribery. Co-defendant John Conigliaro, 60, of Kingsville, was separately charged with conspiracy on February 1, 2022. The Indictment against Edmonds was announced by United States Attorney […]

St. Jude Medical agrees to pay $27 million for allegedly selling defective heart devices

BALTIMORE, MD—St. Jude Medical, Inc. has agreed to pay $27 million to settle allegations under the False Claims Act that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal healthcare programs. St. Jude was acquired by Abbott Laboratories in January 2017. The […]